Citius Pharmaceuticals Inc. is looking to raise $2 million via the sale of 669,504 shares at $2.985 apiece.

The Cranford, N.J.-based company, which is developing treatments for cancer and critical care, will also issue warrants to purchase up to an additional 669,504 shares at $2.86 each.

The offering is expected to close by April 2 with H.C. Wainwright & Co. acting as exclusive placement agent.